🇺🇸 US

AMGN revenue, net income and debt history (Amgen Inc.)

Quick answer

Amgen Inc. (AMGN) reported revenue of $36.75B and net income of $7.71B for the fiscal year ended 2025-12-31, up 10.0% from $33.42B the year before, per its 10-K filed with the SEC on 2026-02-13. Long-term debt stood at $54.60B.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$36.75B$7.71B$54.60B
2024 (FY ending 2024-12-31)$33.42B$4.09B$60.10B
2023 (FY ending 2023-12-31)$28.19B$6.72B$64.61B
2022 (FY ending 2022-12-31)$26.32B$6.55B$38.95B
2021 (FY ending 2021-12-31)$25.98B$5.89B$33.31B
2020 (FY ending 2020-12-31)$25.42B$7.26B$32.99B
2019 (FY ending 2019-12-31)$23.36B$7.84B$29.90B
2018 (FY ending 2018-12-31)$23.75B$8.39B$33.93B
2017 (FY ending 2017-12-31)$22.85B$1.98B$35.34B
2016 (FY ending 2016-12-31)$22.99B$7.72B$34.60B

Related

Last updated 2026-10-16. Data only, not financial or tax advice.